Efficacy, Safety, and Tolerability of Switching from Oral Cholinesterase Inhibitors to Rivastigmine Transdermal Patch with 1-Step Titration in Patients with Mild to Moderate Alzheimer's Disease: A 24-Week, Open-Label, Multicenter Study in Japan
在日本开展的一项为期24周、开放标签、多中心研究,旨在评估从口服胆碱酯酶抑制剂转换为利伐斯的明透皮贴剂并采用一步滴定法治疗轻度至中度阿尔茨海默病患者的疗效、安全性和耐受性。该研究为一项针对轻度至中度阿尔茨海默病患者的研究。
期刊:Dementia and Geriatric Cognitive Disorders Extra
影响因子:1.6
doi:10.1159/000501364
Ueda, Kengo; Katayama, Sadao; Arai, Tetsuaki; Furuta, Nobuo; Ikebe, Shinichiro; Ishida, Yoshinori; Kanaya, Kiyoshi; Ouma, Shinji; Sakurai, Hirofumi; Sugitani, Masato; Takahashi, Makio; Tanaka, Toshihisa; Tsuno, Norifumi; Wakutani, Yosuke; Shekhawat, Ankita; Das Gupta, Ayan; Kiyose, Kazuki; Toriyama, Kazuhiro; Nakamura, Yu